Currently, there are 217.53M common shares owned by the public and among those 184.22M shares have been available to trade.
The company’s stock has a 5-day price change of 1.93% and -7.46% over the past three months. PGRE shares are trading -14.57% year to date (YTD), with the 12-month market performance down to -5.48% lower. It has a 12-month low price of $3.75 and touched a high of $5.47 over the same period. PGRE has an average intraday trading volume of 1.72 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.16%, -2.26%, and -11.47% respectively.
Institutional ownership of Paramount Group Inc (NYSE: PGRE) shares accounts for 65.37% of the company’s 217.53M shares outstanding.
It has a market capitalization of $1.00B and a beta (3y monthly) value of 1.08. The earnings-per-share (ttm) stands at -$0.21. The company has a debt-to-equity ratio at 1.18. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.87% over the week and 3.93% over the month.
Analysts forecast that Paramount Group Inc (PGRE) will achieve an EPS of 0 for the current quarter, 0 for the next quarter and 0 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0 while analysts give the company a high EPS estimate of 0. Earnings per share for the fiscal year are expected to decrease by -9.52%, and -86.96% over the next financial year. EPS should shrink at an annualized rate of -29.87% over the next five years, compared to -5.94% over the past 5-year period.
Looking at the support for the PGRE, a number of firms have released research notes about the stock. Morgan Stanley stated their Underweight rating for the stock in a research note on April 15, 2025, with the firm’s price target at $3.25. Evercore ISI coverage for the Paramount Group Inc (PGRE) stock in a research note released on March 18, 2024 offered a In-line rating with a price target of $5. BofA Securities was of a view on November 13, 2023 that the stock is Underperform, while BofA Securities gave the stock Neutral rating on March 01, 2023, issuing a price target of $5.50. Morgan Stanley on their part issued Equal-Weight rating on November 23, 2022.
